News
Here's Why Quidel Corporation Is Rising Today
Shares of Quidel Corporation (NASDAQ: QDEL), a company focused on diagnostic testing equipment, rose 11% as of 11:45 a.m. EDT on Tuesday in response to the announcement that it is acquiring a few
Better Buy: Intel Corporation vs. Qualcomm
This year has been a bit disappointing for both Intel (NASDAQ: INTC) and Qualcomm (NASDAQ: QCOM) shareholders. Despite posting strong quarters, including Intel's record-breaking start to the year and
Why Kimberly Clark Corp. Stock Gained 13% in 2017 So Far
Consumer products giant Kimberly-Clark (NYSE: KMB) stock added 13% through the first half of 2017, according to data provided by S&P Global Market Intelligence.The boost has helped shareholders
Why Netflix, Inc. Shares Are Soaring Today
Shares of Netflix (NASDAQ: NFLX) jumped Tuesday morning on the heels of Monday night's second-quarter earnings report. As of 11:50 a.m. EDT, the stock was exploring new all-time highs at an overnight
Bank of America Earnings: An Excellent Quarter With Few Weak Spots
Most of the banks that have reported earnings so far have delivered better-than-expected earnings, and Bank of America (NYSE: BAC) was no exception. In addition to strong top- and bottom-line numbers
Invest Like "Royalty" With These 3 Stocks
Investors have been dealt an exceptional hand since March 2009, with all three major U.S. indexes more than tripling in value since their lows. Considering that the stock market has historically
Better Buy: NVIDIA Corporation vs. Cypress Semiconductor
You might be tempted to believe that companies that operate in the semiconductor industry would have similar businesses, but in this case, that couldn't be further from the truth. On the one hand, you
Netflix Now Has Another Way to Keep Theatergoers at Home
Since it rolled out its streaming service a decade ago, Netflix, Inc. (NASDAQ: NFLX) has become the global leader in that area, with more than 100 million subscribers worldwide. The company continues
What Does Barnett Shale Profitability Mean for Oil Stocks?
The Barnett Shale was once the darling of the U.S. oil and gas industry. From 2002 to 2010, it was the most productive source of shale gas in the country. However, it has fallen from its perch in
3 High-Yield Dividend Stocks to Buy in July
It's easy to understand the allure of high-yield dividend stocks. After all, adding a healthy quarterly payout to traditional share price appreciation can be a recipe for market-beating returns over
UnitedHealth Sees a Healthier Future
Healthcare is front and center in Washington once more, and lawmakers have made little progress toward making anticipated changes on the insurance front. In the absence of more reform efforts, health
General Electric Plans to Launch the Mother Lode of Big Metal 3D Printers in 2018
General Electric (NYSE: GE) announced at the Paris Airshow last month that it's developing what appears to be the world's largest laser-based powder-bed fusion metal 3D printer. The machine will be
I Still Can't Believe Ambarella, Inc. Spent $100 Million on Research and Development
Ambarella's (NASDAQ: AMBA) sales footprint shrank last year, but the company got more aggressive on spending rather than less so. Operating costs jumped to 47% of sales from closer to 40% in each of
3 Things Netflix Still Needs to Get Right
Netflix (NASDAQ: NFLX) came through with another blowout report on Monday, and the market's rewarding investors by pushing the stock up to a new all-time high. The leading player in premium video
The Only Promising Part of Amazon's Rumored Messaging Service
Reports surfaced a few days ago that e-commerce giant Amazon.com (NASDAQ: AMZN) is working on a new messaging service called Anytime. I'm generally pretty skeptical about the idea, mostly because the
Despite Falling Drug Sales, Johnson & Johnson Remains Optimistic
Johnson & Johnson (NYSE: JNJ) owes much of its recent success to the strength of its pharmaceutical division. Even though the company also has extensive exposure to other parts of the healthcare
Should You Buy Into the Hype Surrounding These Stocks?
The "hype cycle" is something all investors need to be aware of. The process kicks off whenever the media gets overly excited about a new technology or business advancement, which ends up driving
3 Things This Apple Inc. Supplier Wants You to Know
One of the reasons contract chip manufacturer Taiwan Semiconductor Manufacturing Company (NYSE: TSM) seems to have become more interesting among tech investors is the fact that it's the key
Wells Fargo to Close 450 Branches
Wells Fargo (NYSE: WFC) has long been known among analysts and commentators as one of the nation's most efficient banks. As a result, when its efficiency started to slip recently, the bank responded
Retailers Fight for a Slice of the $27 Billion Back-to-School Shopping Pie
Back-to-school can mean big bucks for retailers, but consumers have become more savvy in how they shop making the competition during the second-biggest shopping season of the year even more intense.On
3 Stocks at 52-Week Highs Still Worth Buying
Stocks near or at their 52-week highs are rarely compelling buys. These highfliers, after all, generally tend to take a breather upon reaching new heights or, worse still, reverse course. With this
Lockheed Martin Corporation Q2 Earnings: Shares Rise, Outlook Boosted
The Lockheed Martin Q2:F17 earnings report was released before opening bell this morning. The defense contractor posted earnings of $3.23 per share on $12.7 billion in revenue, compared to the....
This Rewards Card Is a Huge Success for JPMorgan Chase
Even though JPMorgan Chase's (NYSE: JPM) shares have dropped since the bank reported earnings at the end of last week, investors shouldn't interpret this as a sign that something was wrong with the
5 Big Pharma Stocks With the Best Drug Pipelines
Big pharma companies can't rest on their laurels. Continual research and development is critical to ensure long-term success. Some of that R&D pays off more than others, though.Market research firm
5 Ways Gilead Sciences Could Spend Its Cash Hoard
Gilead Sciences (NASDAQ: GILD) has a growth problem.Long known for its enormous HIV franchise and market share, Gilead branched out into hepatitis C (HCV) in 2012. While that market provided plenty of